M&T Bank’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.16M | Buy |
74,757
+33,337
| +80% | +$515K | ﹤0.01% | 800 |
|
|
2025
Q1 | $616K | Buy |
41,420
+2,906
| +8% | +$43.2K | ﹤0.01% | 990 |
|
|
2024
Q4 | $510K | Sell |
38,514
-4,277
| -10% | -$56.6K | ﹤0.01% | 1159 |
|
|
2024
Q3 | $608K | Buy |
42,791
+2,002
| +5% | +$28.5K | ﹤0.01% | 1097 |
|
|
2024
Q2 | $528K | Sell |
40,789
-445
| -1% | -$5.76K | ﹤0.01% | 1097 |
|
|
2024
Q1 | $573K | Buy |
41,234
+7,310
| +22% | +$102K | ﹤0.01% | 1088 |
|
|
2023
Q4 | $484K | Sell |
33,924
-10,604
| -24% | -$151K | ﹤0.01% | 1139 |
|
|
2023
Q3 | $689K | Buy |
44,528
+4,187
| +10% | +$64.8K | ﹤0.01% | 956 |
|
|
2023
Q2 | $634K | Sell |
40,341
-858
| -2% | -$13.5K | ﹤0.01% | 1028 |
|
|
2023
Q1 | $679K | Buy |
41,199
+14,266
| +53% | +$235K | ﹤0.01% | 1001 |
|
|
2022
Q4 | $420K | Buy |
+26,933
| New | +$420K | ﹤0.01% | 1175 |
|
|
2022
Q3 | – | Sell |
-10,464
| Closed | -$63K | – | 1592 |
|
|
2022
Q2 | $63K | Buy |
+10,464
| New | +$63K | ﹤0.01% | 1494 |
|
|
2021
Q1 | – | Sell |
-10,549
| Closed | -$192K | – | 1618 |
|
|
2020
Q4 | $192K | Sell |
10,549
-7,789
| -42% | -$142K | ﹤0.01% | 1527 |
|
|
2020
Q3 | $327K | Sell |
18,338
-5,858
| -24% | -$104K | ﹤0.01% | 1191 |
|
|
2020
Q2 | $434K | Sell |
24,196
-4,068
| -14% | -$73K | ﹤0.01% | 1000 |
|
|
2020
Q1 | $429K | Sell |
28,264
-1,668
| -6% | -$25.3K | ﹤0.01% | 973 |
|
|
2019
Q4 | $591K | Buy |
29,932
+3,896
| +15% | +$76.9K | ﹤0.01% | 793 |
|
|
2019
Q3 | $448K | Sell |
26,036
-1,520
| -6% | -$26.2K | ﹤0.01% | 1012 |
|
|
2019
Q2 | $488K | Buy |
27,556
+354
| +1% | +$6.27K | ﹤0.01% | 979 |
|
|
2019
Q1 | $554K | Buy |
+27,202
| New | +$554K | ﹤0.01% | 911 |
|